DNA RNA and Cells

14 Nov 2016 Alnylam Pharmaceuticals and The Medicines Company Announce Publication of Phase 1 Clinical Data with Inclisiran (ALN- PCSsc) in the New England Journal of Medicine
14 Nov 2016 MiNA Therapeutics Presents Data Demonstrating Survival Benefit of MTL-CEBPA in Animal Model of Liver Failure at AASLD Liver Meeting
11 Nov 2016 Adaptimmune Announces Update on Clinical Data from NY-ESO SPEAR™ T-cell Synovial Sarcoma Study at the 2016 Annual Meeting of the Connective Tissue Oncology Society (CTOS)
11 Nov 2016 Adaptimmune Presents Preclinical Data from a New, Wholly-owned SPEAR™ T-cell and a Second Generation SPEAR T-cell at the 31st Annual Meeting of the Society for Immunotherapy for Cancer (SITC)
10 Nov 2016 Adaptimmune Announces Removal of Partial Clinical Hold in Myxoid/Round Cell Liposarcoma (MRCLS)
09 Nov 2016 Dynavax Presents Early Clinical Data from Lead Cancer Immunotherapy Candidate, SD-101, at Society for Melanoma Research
09 Nov 2016 Lion Biotechnologies Presents Encouraging TIL Technology Data in Four Posters at 2016 SITC Annual Meeting
09 Nov 2016 Arrowhead Pharmaceuticals Provides Update on Heparc-2004 Study
08 Nov 2016 Elanix Biotechnologies AG Strategic Partner, Transwell Biotechnology Ltd., Receives Us FDA Clearance for Phase I/II Clinical Trial Using Fibroblast Progenitors TWB-103
07 Nov 2016 Sirnaomics Received Green Light from US FDA for a Clinical Phase IIa Study of Its Leading siRNA Therapeutic Candidate, STP705, for Treatment of Hypertrophic Scar
07 Nov 2016 Ascend Biopharmaceuticals Announces Encouraging Phase I/IIa Interim Results of ASN-002 Treatment of Nodular Basal Cell Carcinoma (nBCC)
07 Nov 2016 Biogen and Ionis Pharmaceuticals Announce SPINRAZA (nusinersen) Meets Primary Endpoint at Interim Analysis of Phase 3 CHERISH Study in Later-Onset Spinal Muscular Atrophy
07 Nov 2016 Phase I/IIa Mesothelioma Study completes dosing of patients and further clinical updates
06 Nov 2016 SanBio Presents Interim Results of the First Intracerebral Stem Cell Transplant Study for Stroke in the United States
02 Nov 2016 Bio-Path Holdings Announces First Patient Dosed in Phase 2 Trial Evaluating BP1001 in Acute Myeloid Leukemia
02 Nov 2016 Renova Therapeutics announces successful End-of-Phase 2 meeting with FDA for RT-100 AC6 gene transfer therapy
02 Nov 2016 DNAtrix Announces First Patients Treated in Phase 2 Trial with DNX-2401 and KEYTRUDA
01 Nov 2016 Bellicum and Ospedale Pediatrico Bambino Gesù Announce Expanded Collaboration to Develop Novel CAR T and TCR Cell Therapies Engineered with CaspaCIDe
01 Nov 2016 Ionis Pharmaceuticals Reports Positive Phase 2 Data for IONIS-FXI Rx in Patients with End-Stage Renal Disease on Hemodialysis
28 Oct 2016 Biogen’s Regulatory Applications for Nusinersen as a Treatment for Spinal Muscular Atrophy Accepted by FDA and EMA
26 Oct 2016 OncoGenex Announces Positive Survival Results from Apatorsen Phase 2 Borealis-2™ Trial in Metastatic Bladder Cancer
25 Oct 2016 AmpliPhi Biosciences Announces Favorable Topline Safety and Tolerability Results from Its Phase 1 Trial in Patients with Chronic Rhinosinusitis
24 Oct 2016 Advaxis Announces GOG-0265 12-month Overall Survival Rate of 37.5% in Stage 2
20 Oct 2016 Helix BioPharma Corp. Announces CAR-T Poster Presentation at the AACR Conference on Tumor Immunology and Immunotherapy
20 Oct 2016 Kite Pharma Details KTE-C19 Launch Preparedness and Near-Term, Next Generation CAR/TCR Product Candidates at Investor Day

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing